Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 6 (2009), Issue 11 (November)

1. Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder.
   Brain Behav Immun, 23(8): 1079-82. [Abstract] [Full-text]
2. Early course of bipolar disorder in high-risk offspring: prospective study.
   Br J Psychiatry, 195(5): 457-8. [Abstract] [Full-text]
3. Outcomes of people with psychotic disorders in a community-based rehabilitation programme in rural India.
   Br J Psychiatry, 195(5): 433-9. [Abstract] [Full-text]
4. Parole revocation among prison inmates with psychiatric and substance use disorders.
   Psychiatr Serv, 60(11): 1516-21. [Abstract] [Full-text]
5. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
   J Child Adolesc Psychopharmacol, 19(5): 553-61. [Abstract] [Full-text]
6. Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit/hyperactivity disorder in children and adolescents with bipolar I or II disorder.
   J Child Adolesc Psychopharmacol, 19(5): 547-51. [Abstract] [Full-text]
7. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
   J Child Adolesc Psychopharmacol, 19(5): 539-45. [Abstract] [Full-text]
8. Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic.
   J Child Adolesc Psychopharmacol, 19(5): 529-38. [Abstract] [Full-text]
9. State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study.
   Neurosci Lett, 466(3): 139-43. [Abstract] [Full-text]
10. Bipolar II postpartum depression: Detection, diagnosis, and treatment.
    Am J Psychiatry, 166(11): 1217-21. [Abstract] [Full-text]
11. Enhancing multiyear guideline concordance for bipolar disorder through collaborative care.
    Am J Psychiatry, 166(11): 1244-50. [Abstract] [Full-text]
12. Anxiety and outcome in bipolar disorder.
    Am J Psychiatry, 166(11): 1238-43. [Abstract] [Full-text]
13. Genome-wide linkage and follow-up association study of postpartum mood symptoms.
    Am J Psychiatry, 166(11): 1229-37. [Abstract] [Full-text]
14. Alone together: A grounded theory study of experienced burden, coping, and support needs of spouses of persons with a bipolar disorder.
    Int J Ment Health Nurs, 18(6): 434-43. [Abstract] [Full-text]
15. Is phosphoadenosine phosphate phosphatase a target of lithium's therapeutic effect?
    J Neural Transm, 116(11): 1543-9. [Abstract] [Full-text]
16. Trauma exposure and post-traumatic stress disorder in bipolar disorder.
    Soc Psychiatry Psychiatr Epidemiol, 44(12): 1041-9. [Abstract] [Full-text]
17. Co-occurring medical and mental illness and substance use disorders among veteran clinic users with spinal cord injury patients with complexities.
    Spinal Cord, 47(11): 789-95. [Abstract] [Full-text]
18. Lurasidone: a new drug in development for schizophrenia.
    Expert Opin Investig Drugs, 18(11): 1715-26. [Abstract] [Full-text]
19. Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series.
    J Psychopharmacol, 23(8): 985-7. [Abstract] [Full-text]
20. Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: a case report.
    J Psychopharmacol, 23(8): 1001-3. [Abstract] [Full-text]
21. Subsyndromal Mood Symptoms: A Useful Concept for Maintenance Studies of Bipolar Disorder?
    Psychopathology, 43(1): 1-7. [Abstract] [Full-text]
22. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors.
    Gen Hosp Psychiatry, 31(6): 555-63. [Abstract] [Full-text]
23. Expression of kinase interacting with stathmin (KIS, UHMK1) in human brain and lymphoblasts: Effects of schizophrenia and genotype.
    Brain Res, 1301: 197-206. [Abstract] [Full-text]
24. Positive interference of the analgesic nefopam in the urine immunoassay for benzodiazepines in a secure setting.
    J Psychopharmacol, 23(8): 997. [Abstract] [Full-text]
25. The role of depression, shame-proneness, and guilt-proneness in predicting criticism of relatives towards people with bipolar disorder.
    Behav Ther, 40(4): 315-24. [Abstract] [Full-text]
26. An association analysis between mitochondrial DNA A10398G polymorphism and temperament in Japanese young adults.
    PLoS One, 4(11): e7763. [Abstract] [Full-text]
27. Risperidone in the treatment of mixed state bipolar patients: Results from a 24-week, multicenter, open-label study in Korea.
    Psychiatry Clin Neurosci. [Abstract] [Full-text]
28. Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients.
    Neurosci Lett, 467(2): 67-71. [Abstract] [Full-text]
29. Reduced activation in the mirror neuron system during a virtual social cognition task in euthymic bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(8): 1409-16. [Abstract] [Full-text]
30. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(8): 1366-71. [Abstract] [Full-text]
31. Where should bipolar disorder appear in the meta-structure?
    Psychol Med, 39(12): 2071-81. [Abstract] [Full-text]
32. The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11.
    Psychol Med, 39(12): 2025-42. [Abstract] [Full-text]
33. Is bipolar II depression phenotypically distinctive?
    Acta Psychiatr Scand, 120(6): 446-55. [Abstract] [Full-text]
34. The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ.
    Acta Psychiatr Scand, 120(6): 456-63. [Abstract] [Full-text]
35. Gender differences in bipolar disorder type I and II.
    Acta Psychiatr Scand, 120(6): 464-73. [Abstract] [Full-text]
36. White matter lesions in euthymic patients with bipolar disorder.
    Acta Psychiatr Scand, 120(6): 481-91. [Abstract] [Full-text]
37. Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology.
    Acta Psychiatr Scand, 120(6): 474-80. [Abstract] [Full-text]
38. Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial.
    Acta Psychiatr Scand, 120(6): 441-5. [Abstract] [Full-text]
39. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.
    J Clin Psychiatry, 70(10): 1432-8. [Abstract] [Full-text]
40. Birth-cohort and dual diagnosis effects on age-at-onset in Brazilian patients with bipolar I disorder.
    Acta Psychiatr Scand, 120(6): 492-5. [Abstract] [Full-text]
41. Negative life events in children and adolescents with bipolar disorder.
    J Clin Psychiatry, 70(10): 1452-60. [Abstract] [Full-text]
42. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
    J Clin Psychiatry, 70(10): 1441-51. [Abstract] [Full-text]
43. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    J Clin Psychiatry, 70(10): 1424-31. [Abstract] [Full-text]
44. Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    J Clin Psychiatry, 70(10): 1407-15. [Abstract] [Full-text]
45. Glucocorticoid Receptor Polymorphisms in Major Depression.
    Ann N Y Acad Sci, 1179(1): 199-215. [Abstract] [Full-text]
46. Effects of Glucocorticoids on Mood, Memory, and the Hippocampus.
    Ann N Y Acad Sci, 1179(1): 41-55. [Abstract] [Full-text]
47. Medical comorbidity among youth diagnosed with bipolar disorder in the United States.
    J Clin Psychiatry, 70(10): 1461-6. [Abstract] [Full-text]
48. Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder.
    Schizophr Res, 115(2): 115-20. [Abstract] [Full-text]
49. Five-year stability of ICD-10 diagnoses among Chinese patients presented with first-episode psychosis in Hong Kong.
    Schizophr Res, 115(2): 351-7. [Abstract] [Full-text]
50. Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder.
    Schizophr Res, 115(2): 156-62. [Abstract] [Full-text]
51. Maternal age and paternal age are associated with distinct childhood behavioural outcomes in a general population birth cohort.
    Schizophr Res, 115(2): 130-5. [Abstract] [Full-text]
52. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
    J Clin Psychopharmacol, 29(6): 595-600. [Abstract] [Full-text]
53. Number needed to treat or harm analyses of olanzapine for maintenance treatment of bipolar disorder.
    J Clin Psychopharmacol, 29(6): 520-8. [Abstract] [Full-text]
54. GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlations.
    Biochem Soc Trans, 37: 1415-8. [Abstract] [Full-text]
55. A case-control association study and family-based expression analysis of the bipolar disorder candidate gene PI4K2B.
    J Psychiatr Res, 43(16): 1272-7. [Abstract] [Full-text]
56. Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues.
    J Med Chem, 52(22): 7236-48. [Abstract] [Full-text]
57. Asenapine versus olanzapine in acute mania: a double-blind extension study.
    Bipolar Disord, 11(8): 815-26. [Abstract] [Full-text]
58. A preliminary investigation of the effect of hypomanic personality on the specificity and speed of autobiographical memory recall.
    Memory. [Abstract] [Full-text]
59. Impact of psychotic features on morbidity and course of illness in patients with bipolar disorder.
    Eur Psychiatry. [Abstract] [Full-text]
60. Effects of night shifts in bipolar disorders and extreme morningness.
    Bipolar Disord, 11(8): 897-9. [Abstract] [Full-text]
61. Suicidal ideation and depressive symptoms among bipolar patients as predictors of the health and well-being of caregivers.
    Bipolar Disord, 11(8): 876-84. [Abstract] [Full-text]
62. Stability of symptoms across major depressive episodes in bipolar disorder.
    Bipolar Disord, 11(8): 867-75. [Abstract] [Full-text]
63. Relationships between auditory event-related potentials and mood state, medication, and comorbid psychiatric illness in patients with bipolar disorder.
    Bipolar Disord, 11(8): 857-66. [Abstract] [Full-text]
64. Functional imaging of emotional memory in bipolar disorder and schizophrenia.
    Bipolar Disord, 11(8): 840-56. [Abstract] [Full-text]
65. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
    Bipolar Disord, 11(8): 827-39. [Abstract] [Full-text]
66. Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies.
    Bipolar Disord, 11(8): 807-14. [Abstract] [Full-text]
67. The role of dopamine in bipolar disorder.
    Bipolar Disord, 11(8): 787-806. [Abstract] [Full-text]
68. Gray and white matter brain volumes in older adults with bipolar disorder.
    Int J Geriatr Psychiatry, 24(12): 1445-52. [Abstract] [Full-text]
69. Genetic variation in neuregulin1 is associated with differences in prefrontal engagement in children.
    Hum Brain Mapp, 30(12): 3934-43. [Abstract] [Full-text]
70. Alterations in functional activation in euthymic bipolar disorder and schizophrenia during a working memory task.
    Hum Brain Mapp, 30(12): 3958-69. [Abstract] [Full-text]
71. Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression.
    Psychiatry Res, 170(2): 150-6. [Abstract] [Full-text]
72. Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.
    Ther Drug Monit, 31(6): 758-63. [Abstract] [Full-text]
73. Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies.
    Int J Clin Pract, 63(12): 1743-61. [Abstract] [Full-text]
74. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
    Int J Clin Pract, 63(12): 1762-84. [Abstract] [Full-text]
75. A novel scale for measuring mixed states in bipolar disorder.
    Clin Psychol Psychother, 16(6): 497-509. [Abstract] [Full-text]
76. Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness.
    Pharmacol Ther, 124(3): 269-78. [Abstract] [Full-text]
77. No cathartic effect in suicide attempters admitted to the emergency department.
    J Psychiatr Pract, 15(6): 433-41. [Abstract] [Full-text]
78. Using A Pharmacy-Based Intervention To Improve Antipsychotic Adherence Among Patients With Serious Mental Illness.
    Schizophr Bull. [Abstract] [Full-text]
79. Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level.
    BMC Neurosci, 10: 132. [Abstract] [Full-text]
80. Abnormally increased effective connectivity between parahippocampal gyrus and ventromedial prefrontal regions during emotion labeling in bipolar disorder.
    Psychiatry Res, 174(3): 195-201. [Abstract] [Full-text]
81. Evidence for genetic association of RORB with bipolar disorder.
    BMC Psychiatry, 9: 70. [Abstract] [Full-text]
82. Preliminary study in patients with obsessive-compulsive disorder treated with electrical stimulation in the inferior thalamic peduncle.
    Neurosurgery, 65(6): 203-9; discussion 209. [Abstract] [Full-text]
83. Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-I disorder.
    Med Care, 47(12): 1217-28. [Abstract] [Full-text]
84. Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder.
    Prostaglandins Leukot Essent Fatty Acids. [Abstract] [Full-text]
85. On the specificity of positive emotional dysfunction in psychopathology: Evidence from the mood and anxiety disorders and schizophrenia/schizotypy.
    Clin Psychol Rev. [Abstract] [Full-text]
86. Genetic overlap between polycystic ovary syndrome and bipolar disorder: the endophenotype hypothesis.
    Med Hypotheses, 73(6): 996-1004. [Abstract] [Full-text]
87. Genetic overlap between autism, schizophrenia and bipolar disorder.
    Genome Med, 1(10): 102. [Abstract] [Full-text]
88. Lithium and thyroid.
    Best Pract Res Clin Endocrinol Metab, 23(6): 723-33. [Abstract] [Full-text]
89. Gene-environment interaction tests for dichotomous traits in trios and sibships.
    Genet Epidemiol, 33(8): 691-9. [Abstract] [Full-text]
90. Interspecies trait genetics reveals association of Adcy8 with mouse avoidance behavior and a human mood disorder.
    Biol Psychiatry, 66(12): 1123-30. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.